CLSA Downgrades CanSino Biologics (6185:HK) to Outperform (2)
Tweet
Share
E-mailGet Alerts 6185:HK Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 10 | New: 12
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 10 | New: 12
Trade Now!
Join SI Premium – FREE
CLSA analyst Tony Ren downgraded CanSino Biologics (6185:HK) from Buy (1) to Outperform (2) with a price target of HK$310.00 (from HK$53.45).
You May Also Be Interested In
- Aker BP (AKERBP:NO) (DETNF) PT Raised to NOK271 at Jefferies
- Metro Inc. (MRU:CN) (MTRAF) PT Raised to Cdn$61 at TD Securities
- Mullen Group (MTL:CN) (MLLGF) PT Raised to Cdn$17 at TD Securities
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
